Browsing by Yonsei Author : Sohn, Joo Hyuk

Name:
Sohn, Joo Hyuk [손주혁] http://orcid.org/0000-0002-2303-2764
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Y-HRN :
(Yonsei Health Research Network)
Scopus ID :
(15045889800)

Keyword Cloud

Researcher Network

This table browses all dspace content
Issue DateTitleJournal Title
2020Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer EXPERIMENTAL AND MOLECULAR MEDICINE
2020Intermediate HER2 Expression Is Associated With Poor Prognosis in Estrogen Receptor-Positive Breast Cancer Patients Aged 55 Years and OlderBREAST CANCER RESEARCH AND TREATMENT
2019Establishment of Chemosensitivity Tests in Triple-Negative and BRCA-mutated Breast Cancer Patient-Derived Xenograft Models PLOS ONE
2019Local Treatment in Addition to Endocrine Therapy in Hormone Receptor-Positive and HER2-Negative Oligometastatic Breast Cancer Patients: A Retrospective Multicenter AnalysisBREAST CARE
2019A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide CANCER RESEARCH AND TREATMENT
2019차세대 염기서열 분석법과 항암요법 JOURNAL OF THE KOREAN MEDICAL ASSOCIATION
2019Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01) CANCER RESEARCH AND TREATMENT
2019Risk of Lymphedema Following Contemporary Treatment for Breast Cancer: An Analysis of 7617 Consecutive Patients From a Multidisciplinary PerspectiveEUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
2019Effect of primary tumor resection on overall survival in patients with stage IV breast cancerBREAST JOURNAL
2018Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's PerspectiveCLINICAL BREAST CANCER
2018Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients CANCER RESEARCH AND TREATMENT
2018Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials.JOURNAL OF GLOBAL ONCOLOGY
2018External validation of IBTR! 2.0 nomogram for prediction of ipsilateral breast tumor recurrence Radiation Oncology Journal
2018CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator ONCOTARGET
2018The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea ControlCANCER NURSING
2017Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancerBREAST CANCER RESEARCH AND TREATMENT
2017Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer PLOS ONE
2017Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results ANNALS OF SURGICAL TREATMENT AND RESEARCH
2017Chemotherapy-induced irreversible alopecia in early breast cancer patientsBREAST CANCER RESEARCH AND TREATMENT
2017Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in Korea JOURNAL OF BREAST CANCER
2017An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast CancerCANCER RESEARCH AND TREATMENT
2017Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort studyEUROPEAN JOURNAL OF CANCER
2017Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR YONSEI MEDICAL JOURNAL
2016Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer PLOS ONE
2016Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer ONCOTARGET
2016Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy JOURNAL OF BREAST CANCER
2016Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study CANCER RESEARCH AND TREATMENT
2016The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer. PLOS ONE
2015Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assayINTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
2015Prediction of short- and long-term survival for advanced cancer patients after ICU admissionSUPPORTIVE CARE IN CANCER
2015Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence? MEDICINE
2015성장인자수용체-2 양성 유방암 조직에서 표적치료 전후의 성장인자수용체군 발현양상 Korean Journal of Clinical Oncology (대한임상종양학회지)
2015Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication PLOS ONE
2014Patient-Reported Outcomes From EMILIA, a Randomized Phase 3 Study of Trastuzumab Emtansine (T-DM1) Versus Capecitabine and Lapatinib in Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Breast CancerCANCER
2014cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer JOURNAL OF CANCER
2013Multicentre phase II trial of bevacizumab combined with docetaxel–carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905) ANNALS OF ONCOLOGY
2013Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors SUPPORTIVE CARE IN CANCER
2013Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapy ANNALS OF ONCOLOGY
2013S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial BMC CANCER
2013Prolonged clinical benefit from the maintenance hormone therapy in patients with metastatic breast cancerBREAST
2013A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancerINVESTIGATIONAL NEW DRUGS
2012Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogram NEURO-ONCOLOGY
2012Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.LANCET
2012Metaplastic breast cancer: clinicopathological features and its prognosisJOURNAL OF CLINICAL PATHOLOGY
2012Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy PLOS ONE
2011Molecular Subtypes and Tumor Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast CancerONCOLOGY
2011A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results.LUNG CANCER
2011Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen.JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2011Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP).LAB ON A CHIP
2011Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptinBIOMATERIALS
12

Browse

Links